首页 | 本学科首页   官方微博 | 高级检索  
     

DNA修复基因XPD XPC XRCC4基因多态性与结直肠癌易感性的关联性研究
引用本文:张莎,陈自平,杜文军,熊宏超,徐昌青. DNA修复基因XPD XPC XRCC4基因多态性与结直肠癌易感性的关联性研究[J]. 中国肿瘤临床, 2017, 44(8): 365-370. DOI: 10.3969/j.issn.1000-8179.2017.08.385
作者姓名:张莎  陈自平  杜文军  熊宏超  徐昌青
作者单位:①.山东大学附属千佛山医院消化内科(济南市250014)
基金项目:本文课题受山东省科技发展计划项目(编号:2013G0021823)资助This work was supported by the Program of Shandong Province Science and Technology Development Plans (2013G0021823)
摘    要:  目的  探讨DNA修复基因XPD rs13181(codon751A/C,Lys751Gln)、rs238406(codon156C/A,Arg156Arg)、XPC rs2279017(i11C/A)和XRCC4 rs3734091(codon247T/C,Ala247Ser)的单核苷酸多态性与结直肠癌易感性的关系。  方法  采用TaqMan技术对2013年4月至2016年1月北京肿瘤医院收治的338例结直肠癌患者(病例组)和315例健康者(对照组)进行多态位点基因型的检测。  结果  XPD rs13181基因型GT和等位基因G增加个体结直肠癌的发病风险(GT>TT,adjusted OR=1.69,95%CI:1.15~2.47,P=0.007;G>T,adjusted OR=1.77,95%CI:1.19~2.64,P=0.005);XRCC4 rs3734091基因型GT和等位基因T增加个体结直肠癌的易感性(GT>GG,adjusted OR=9.02,95%CI:5.61~14.50,P<0.001;T>G,adjusted OR=4.06,95%CI:2.49~6.61,P<0.001);XPD rs13181和rs238406的单倍体型GT显著降低结直肠癌的发病风险(adjusted OR=0.39,95%CI:0.18~0.85,P=0.018)。XPCrs2279017等位基因G和XRCC4 rs3734091等位基因T的联合效应(adjusted OR=28.43,95%CI:6.85~117.95,P<0.001)以及XPD rs13181等位基因G和XRCC4 rs3734091等位基因T的联合效应(adjusted OR=10.24,95%CI:4.69~22.35,P<0.001)显著增加个体结直肠癌的易感性。  结论  XPD rs13181和XRCC4 rs3734091位点的多态性与结直肠癌的易感性相关。 

关 键 词:XPD   XPC   XRCC4   单核苷酸多态性   结直肠癌   TaqMan技术
收稿时间:2016-12-01

Genetic polymorphisms of DNA repair genes XPD,XPC, and XRCC4 in relation to colorectal cancer susceptibility
Sha ZHANG,Ziping CHEN,Wenjun DU,Hongchao XIONG,Changqing XU. Genetic polymorphisms of DNA repair genes XPD,XPC, and XRCC4 in relation to colorectal cancer susceptibility[J]. Chinese Journal of Clinical Oncology, 2017, 44(8): 365-370. DOI: 10.3969/j.issn.1000-8179.2017.08.385
Authors:Sha ZHANG  Ziping CHEN  Wenjun DU  Hongchao XIONG  Changqing XU
Affiliation:①.Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, China②.Department of Thoracic Surgery, Beijing Cancer Hospital, Beijing 100142, China
Abstract:Objective:To investigate the association of XPD rs13181 (codon751A/C, Lys751Gln), rs238406 (codon156C/A, Arg156Arg), XPC rs2279017 (i11C/A), and XRCC4 rs3734091 (codon247T/C, Ala247Ser) polymorphisms with colorectal cancer (CRC) susceptibility. Methods:A total of 338 patients with CRC who were treated at the Beijing Cancer Hospital from April 2013 to January 2016 (case group) and 315 healthy controls (control group) were genotyped using TaqMan technology. Results:The genotype GT and G alleles of XPD rs13181 increased the risk of CRC (GT>TT, adjusted OR=1.69, 95%CI=1.15-2.47, P=0.007;G>T, adjusted OR=1.77, 95%CI=1.19-2.64, P=0.005). The genotype GT and T alleles of XRCC4 rs3734091 increased the susceptibility of CRC (GT>GG, adjusted OR=9.02, 95%CI=5.61-14.50, P<0.001;T>G, adjusted OR=4.06, 95%CI=2.49-6.61, P<0.001). Analyses of XPD rs13181 and rs238406 indicated that the haplotype GT significantly decreased the risk of CRC (adjusted OR=0.39, 95%CI=0.18-0.85, P=0.018). Moreover, the combinations of the XPC rs2279017 G allele and the XRCC4 rs3734091 T allele (adjusted OR=28.43, 95%CI=6.85-117.95, P<0.001) and the XPD rs13181 G allele and the XRCC4 rs3734091 T allele (adjusted OR=10.24, 95%CI=4.69-22.35, P<0.001) exhibited significantly increased CRC risk. Conclusion:The polymorphisms of XPD rs13181 and XRCC4 rs3734091 increased the risk of CRC.
Keywords:XPD  XPC  XRCC4  single-nucleotide polymorphism  colorectal cancer  TaqMan technology
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号